NFE2L2 and Parkinson disease: As Nrf2 is the master regulator of many protective genes, it may be a therapeutic target for some neurological diseases, including Alzheimer’s disease, SCI, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and stroke, etc. (Samarghandian et al., 2020).